Latest Infectious mononucleosis Stories
WICHITA, Kan., June 4, 2014 The Epstein-Barr virus (EBV) is a member of the herpes family that targets lymphocytes and epithelial cells.
Antibody prevalence (for EBV), adjusted for age and sex in non-Hispanic blacks is 74%, much higher than other segments of the population, according to an article published on May 11, 2014 in Clinical
There is “an increased frequency of latent EBV-infected B cells in MS,” according to a study published in Acta Neurologica Scandinavica on March 31, 2014 (1).
Large families and smoking have an independent impact on EBV infection that is not accounted for by other sociodemographic factors, according to a new study published in PLoS One in May, 2013.
More than 90 percent of humans have antibodies to the Epstein Barr virus.
The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis (MS).
Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes.
People who are exposed to low levels of sunlight coupled with a history of having a common virus known as mononucleosis may be at greater odds of developing multiple sclerosis (MS), according to this study.